Replay available

United Therapeutics Corporation (UTHR) Q2 2023 Earnings Call

United Therapeutics Corporation (NASDAQ: UTHR) Q2 2023 earnings conference call, held 2023-08-02. Replay captured from the company's public earnings webcast.

Wed, August 2, 2023 at 9:00 AMendedReplay
United Therapeutics Corporation (UTHR) Q2 2023 Earnings Call

Hosted by

Featured presenters

Dewey Steadman

Head of Investor Relations, United Therapeutics Corporation

Dr. Martine Rothblatt

Chairperson and Chief Executive Officer, United Therapeutics Corporation

Michael Binkowitz

President and Chief Operating Officer, United Therapeutics Corporation

Dr. Lee Peterson

Senior Vice President of Product Development, United Therapeutics Corporation

James Edgemond

Chief Financial Officer and Treasurer, United Therapeutics Corporation

Ash Burma

Analyst, UBS

Eun Yang

Analyst, Jefferies

Hartaj Singh

Analyst, Oppenheimer & Co.

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for United Therapeutics Corporation.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:05.952 Good morning and welcome to the United Therapeutics Corporation second quarter 2023 00:00:05.952 -- 00:00:11.415 earnings webcast. My name is Danielle and I will be your conference operator today. 00:00:11.415 -- 00:00:16.017 All participants on the call portion of this webcast will be in listen-only mode until 00:00:16.017 -- 00:00:19.059 the question and answer portion of this earnings call. 00:00:19.059 -- 00:00:22.360 If you would like to ask a question during that time, 00:00:22.360 -- 00:00:26.002 simply press star then the number 1 on your telephone keypad. 00:00:26.002 -- 00:00:30.051 If you would like to withdraw your question, please press star then 2. 00:00:30.051 -- 00:00:35.894 Please note this call is being recorded. I will now turn the webcast over to Dewey Steadman, 00:00:35.894 -- 00:00:39.455 Head of Investor Relations at United Therapeutics. 00:00:40.077 -- 00:00:44.739 Thanks, Danielle, and good morning. It's my pleasure to welcome you to the United Therapeutics 00:00:44.739 -- 00:00:47.901 Corporation second quarter 2023 earnings 00:00:47.901 -- 00:00:51.203 webcast. Accompanying me on today's webcast are Dr. 00:00:51.203 -- 00:00:55.665 Martine Rothblatt, our Chairperson and Chief Executive Officer, Michael Binkowitz, our 00:00:55.665 -- 00:01:00.226 President and Chief Operating Officer, James Edgemond, our Chief Financial Officer and 00:01:00.226 -- 00:01:05.470 Treasurer, Pat Poisson, our Executive Vice President of Technical Operations, and Dr. 00:01:05.470 -- 00:01:09.072 Lee Peterson, our Senior Vice President of Product Development. 00:01:09.072 -- 00:01:13.115 Please note that remarks today will include forward-looking statements representing our 00:01:13.115 -- 00:01:16.918 expectations or beliefs reg...